Wells Fargo
OM icon

Wells Fargo’s Outset Medical OM Stock Holding History

Wells Fargo’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.1K Sell
6,282
-11,989
-66% -$49.1K ﹤0.01% 5703
2025
Q4 		$67.8K Buy
18,271
+6,632
+57% +$56.9K ﹤0.01% 5498
2025
Q3 		$164K Buy
11,639
+1,129
+11% +$17.6K ﹤0.01% 5049
2025
Q2 		$202K Buy
+10,510
New +$164K ﹤0.01% 4763
2024
Q4 		– Sell
-1
Closed -$7 – 7160
2024
Q3 		$7 Hold
1
– – ﹤0.01% 6721
2024
Q2 		$42 Sell
1
-1,058
-100% -$51.8K ﹤0.01% 6347
2024
Q1 		$35.3K Sell
1,059
-3,102
-75% -$157K ﹤0.01% 5388
2023
Q4 		$338K Sell
4,161
-156
-4% -$12.7K ﹤0.01% 4136
2023
Q3 		$705K Sell
4,317
-911
-17% -$215K ﹤0.01% 3553
2023
Q2 		$1.71M Buy
5,228
+533
+11% +$163K ﹤0.01% 3039
2023
Q1 		$1.3M Buy
4,695
+868
+23% +$319K ﹤0.01% 3198
2022
Q4 		$1.48M Sell
3,827
-648
-14% -$183K ﹤0.01% 2988
2022
Q3 		$1.07M Sell
4,475
-401
-8% -$107K ﹤0.01% 3196
2022
Q2 		$1.09M Sell
4,876
-6,866
-58% -$2.95M ﹤0.01% 3242
2022
Q1 		$8M Buy
11,742
+29
+0.2% +$17.4K ﹤0.01% 2040
2021
Q4 		$8.1M Sell
11,713
-128,416
-92% -$95M ﹤0.01% 2046
2021
Q3 		$104M Buy
140,129
+56,697
+68% +$38.6M 0.02% 636
2021
Q2 		$62.5M Buy
83,432
+55,844
+202% +$42.7M 0.01% 932
2021
Q1 		$22.5M Buy
27,588
+16,930
+159% +$13.1M 0.01% 1588
2020
Q4 		$9.09M Buy
10,658
+322
+3% +$248K ﹤0.01% 2161
2020
Q3 		$7.75M Buy
+10,336
New +$8.49M ﹤0.01% 2097

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wells Fargo's OM Position: Q1 2026 in Review

Wells Fargo reduced its Outset Medical (OM) stake by 66% in Q1 2026, selling an estimated $49.1K and leaving 6,282 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5703.

Wells Fargo first reported a position in OM in Q3 2020 and has held it in 21 quarters since. The position peaked at $104M in Q3 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Wells Fargo held 6,282 shares of Outset Medical worth $24.1K as of Q1 2026.
  • Wells Fargo sold 11,989 Outset Medical shares in Q1 2026, an estimated $49.1K.
  • Outset Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5703 holding.
  • Wells Fargo first reported a position in Outset Medical in Q3 2020 and has held it in 21 quarters since.
  • Wells Fargo's Outset Medical position peaked at $104M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.